The Children's Oncology Group's 2013 five year blueprint for research

Pediatric Blood and Cancer

Volumn 60, Issue 6, 2013, Pages 955-956

  Adamson, Peter C ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CLINICAL TRIAL (TOPIC); EDITORIAL; GENE SEQUENCE; HUMAN; PRIORITY JOURNAL;

CHILD; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; RESEARCH; TIME FACTORS;

EID: 84876455138     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24399     Document Type: Editorial

References (12)

1. Farber S, Diamond LK, Mercer RD, et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-aminopteroylglutamic acid (aminopterin). N Engl J Med 1948; 28: 787-793.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
3. Adamson PC, Blaney SM. New approaches to drug development in pediatric oncology. Cancer J 2005; 11: 324-330.
4. Bhatia S, Meadows AT. Long-term follow-up of childhood cancer survivors: Future directions for clinical care and research. Pediatr Blood Cancer 2006; 46: 143-148.
5. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-1582.
6. Norris RE, Adamson PC. Challenges and opportunities in childhood cancer drug development. Nat Rev Cancer 2012; 12: 776-782. DOI: 10.1038/nrc3370 Epub 2012 Oct 11.
7. Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: Challenges for the twenty-first century. J Clin Oncol 2010; 28: 2625-2634.
8. Mardis ER. A decade's perspective on DNA sequencing technology. Nature 2011; 470: 198-203.
9. O'Leary M, Krailo M, Anderson JR, et al. Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group. Semin Oncol 2008; 35: 484-493.
10. Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine. 2010; A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. National Academies Press http://www.nap.edu/catalog.php?record_id=12879%3E
11. Dilts D. US cancer trials may go the way of the Oldsmobile. Nat Med 2010; 16: 632.
12. Dilts DM, Cheng SK, Crites JS, et al. Phase III clinical trial development: a process of chutes and ladders. Clin Cancer Res 2010; 16: 5381-5389.